These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35469920)

  • 1. Identification of a reciprocal negative feedback loop between tau-modifying proteins MARK2 kinase and CBP acetyltransferase.
    Tabassum Z; Tseng JH; Isemann C; Tian X; Chen Y; Herring LE; Cohen TJ
    J Biol Chem; 2022 Jun; 298(6):101977. PubMed ID: 35469920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated MARK2-dependent phosphorylation of Tau in Alzheimer's disease.
    Gu GJ; Wu D; Lund H; Sunnemark D; Kvist AJ; Milner R; Eckersley S; Nilsson LN; Agerman K; Landegren U; Kamali-Moghaddam M
    J Alzheimers Dis; 2013; 33(3):699-713. PubMed ID: 23001711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Study of Posttranslational Modifications of Tau Protein by Nuclear Magnetic Resonance Spectroscopy: Phosphorylation of Tau Protein by ERK2 Recombinant Kinase and Rat Brain Extract, and Acetylation by Recombinant Creb-Binding Protein.
    Qi H; Despres C; Prabakaran S; Cantrelle FX; Chambraud B; Gunawardena J; Lippens G; Smet-Nocca C; Landrieu I
    Methods Mol Biol; 2017; 1523():179-213. PubMed ID: 27975251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of human Tau protein by microtubule affinity-regulating kinase 2.
    Schwalbe M; Biernat J; Bibow S; Ozenne V; Jensen MR; Kadavath H; Blackledge M; Mandelkow E; Zweckstetter M
    Biochemistry; 2013 Dec; 52(50):9068-79. PubMed ID: 24251416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSK-3beta directly phosphorylates and activates MARK2/PAR-1.
    Kosuga S; Tashiro E; Kajioka T; Ueki M; Shimizu Y; Imoto M
    J Biol Chem; 2005 Dec; 280(52):42715-22. PubMed ID: 16257959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262.
    Drewes G; Trinczek B; Illenberger S; Biernat J; Schmitt-Ulms G; Meyer HE; Mandelkow EM; Mandelkow E
    J Biol Chem; 1995 Mar; 270(13):7679-88. PubMed ID: 7706316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase (GSK) 3beta directly phosphorylates Serine 212 in the regulatory loop and inhibits microtubule affinity-regulating kinase (MARK) 2.
    Timm T; Balusamy K; Li X; Biernat J; Mandelkow E; Mandelkow EM
    J Biol Chem; 2008 Jul; 283(27):18873-82. PubMed ID: 18424437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Semisynthesis Provides Access to Tau Disease-Associated Post-translational Modifications (PTMs) and Paves the Way to Deciphering the Tau PTM Code in Health and Diseased States.
    Haj-Yahya M; Lashuel HA
    J Am Chem Soc; 2018 May; 140(21):6611-6621. PubMed ID: 29684271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase A rescues microtubule affinity-regulating kinase 2-induced microtubule instability and neurite disruption by phosphorylating serine 409.
    Deng SS; Wu LY; Wang YC; Cao PR; Xu L; Li QR; Liu M; Zhang L; Jiang YJ; Yang XY; Sun SN; Tan MJ; Qian M; Zang Y; Feng L; Li J
    J Biol Chem; 2015 Jan; 290(5):3149-60. PubMed ID: 25512381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation.
    Acosta DM; Mancinelli C; Bracken C; Eliezer D
    J Biol Chem; 2022 Jan; 298(1):101442. PubMed ID: 34838590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity.
    Biernat J; Wu YZ; Timm T; Zheng-Fischhöfer Q; Mandelkow E; Meijer L; Mandelkow EM
    Mol Biol Cell; 2002 Nov; 13(11):4013-28. PubMed ID: 12429843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.
    Schneider A; Biernat J; von Bergen M; Mandelkow E; Mandelkow EM
    Biochemistry; 1999 Mar; 38(12):3549-58. PubMed ID: 10090741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DAPK activates MARK1/2 to regulate microtubule assembly, neuronal differentiation, and tau toxicity.
    Wu PR; Tsai PI; Chen GC; Chou HJ; Huang YP; Chen YH; Lin MY; Kimchi A; Chien CT; Chen RH
    Cell Death Differ; 2011 Sep; 18(9):1507-20. PubMed ID: 21311567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable microtubules and dynamic actin.
    Matenia D; Griesshaber B; Li XY; Thiessen A; Johne C; Jiao J; Mandelkow E; Mandelkow EM
    Mol Biol Cell; 2005 Sep; 16(9):4410-22. PubMed ID: 16014608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.
    Billingsley ML; Kincaid RL
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):577-91. PubMed ID: 9169588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model.
    Chatterjee S; Sang TK; Lawless GM; Jackson GR
    Hum Mol Genet; 2009 Jan; 18(1):164-77. PubMed ID: 18930955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The microtubule-associated tau protein has intrinsic acetyltransferase activity.
    Cohen TJ; Friedmann D; Hwang AW; Marmorstein R; Lee VM
    Nat Struct Mol Biol; 2013 Jun; 20(6):756-62. PubMed ID: 23624859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-Cell NMR Study of Tau and MARK2 Phosphorylated Tau.
    Zhang S; Wang C; Lu J; Ma X; Liu Z; Li D; Liu Z; Liu C
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies.
    Lund H; Gustafsson E; Svensson A; Nilsson M; Berg M; Sunnemark D; von Euler G
    Acta Neuropathol Commun; 2014 Feb; 2():22. PubMed ID: 24533944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau therapeutic strategies for the treatment of Alzheimer's disease.
    Churcher I
    Curr Top Med Chem; 2006; 6(6):579-95. PubMed ID: 16712493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.